Clinical Trial Update: Tafenoquine Thorough QTc Study in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 thorough QTc study of tafenoquine in healthy subjects has been completed to assess potential effects on the QT interval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• KRINTAFEL (tafenoquine succinate)
• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 1 | Status: COMPLETED